ALLMedicine™ Hepatitis Center

Feb 27th, 2021 - We present a case of 48-year-old woman with relapsing remitting multiple sclerosis (MS), who switched disease modifying therapy from Copaxone to Fingolimod due to her clinical and radiological MS disease progression. Unexpectedly after 2.5 years o...

Feb 27th, 2021 - Despite a dramatic reduction in HCV drug costs and simplified models of care, many countries lack important information on prevalence and risk factors to structure effective HCV services. A cross-sectional, multi-stage cluster survey of HCV seropr...

Feb 27th, 2021 - Liver cirrhosis is the primary risk factor for the development of hepatocellular carcinoma (HCC). Most conditions that lead to cirrhosis are treatable, or modifiable. Therefore, a community-based screening program targeting high-risk groups was de...

Feb 27th, 2021 - Late recurrence of hepatocellular carcinoma (HCC) is regarded as de novo HCC from chronic hepatitis. This study investigated clinicopathological and molecular factors to develop a nomogram for predicting late HCC recurrence (> 2 years after curati...

Feb 26th, 2021 - To assess the role of TE in HIV infected patients with NAFLD. HIV infected patients undergoing ART were enrolled between August2016 and February2017. ≥18 years with undetectable HIV viral load. pregnancy; alcohol intake ≥20g/day and co-infection w...

Feb 6th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Feb 2nd, 2021 - Hepatitis C virus (HCV) infection and its complications have been the major cause of cirrhosis and its complications for several decades in the Western world. Until recently, treatment for HCV with interferon-based regimens was associated with mod...

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...

Jan 4th, 2021 - Primary liver cancer has the sixth highest incidence and fourth highest cancer mortality worldwide. Hepatitis B is the leading cause of liver cancer, though its incidence is decreasing with vaccination. Alcohol is the leading cause of liver transp...

Dec 15th, 2020 - An estimated 862 000 persons in the US are living with chronic infection with hepatitis B virus (HBV). Persons born in regions with a prevalence of HBV infection of 2% or greater, such as countries in Africa and Asia, the Pacific Islands, and part...

Feb 27th, 2021 - We present a case of 48-year-old woman with relapsing remitting multiple sclerosis (MS), who switched disease modifying therapy from Copaxone to Fingolimod due to her clinical and radiological MS disease progression. Unexpectedly after 2.5 years o...

Feb 27th, 2021 - Despite a dramatic reduction in HCV drug costs and simplified models of care, many countries lack important information on prevalence and risk factors to structure effective HCV services. A cross-sectional, multi-stage cluster survey of HCV seropr...

Feb 27th, 2021 - Liver cirrhosis is the primary risk factor for the development of hepatocellular carcinoma (HCC). Most conditions that lead to cirrhosis are treatable, or modifiable. Therefore, a community-based screening program targeting high-risk groups was de...

Feb 27th, 2021 - Late recurrence of hepatocellular carcinoma (HCC) is regarded as de novo HCC from chronic hepatitis. This study investigated clinicopathological and molecular factors to develop a nomogram for predicting late HCC recurrence (> 2 years after curati...

Feb 26th, 2021 - To assess the role of TE in HIV infected patients with NAFLD. HIV infected patients undergoing ART were enrolled between August2016 and February2017. ≥18 years with undetectable HIV viral load. pregnancy; alcohol intake ≥20g/day and co-infection w...

Feb 8th, 2021 - NEW YORK (Reuters Health) - Ultrasound-based controlled attenuation parameter (CAP), a noninvasive tool for assessment of hepatic steatosis, should be used with caution because while results are reliable in patients with viral hepatitis, that's no...

Feb 2nd, 2021 - NEW YORK (Reuters Health) - The United States has made progress in identifying infants born to hepatitis B surface antigen (HBsAg)-positive women and getting them vaccinated. Yet, there is also substantial room for improvement, including closing t...

Feb 1st, 2021 - The incidence of autoimmune hepatitis (AIH) may be rising, according to a prospective population-based study conducted in New Zealand. From 2008 to 2016, the rising incidence of AIH led to a 40% increase in point prevalence, reported lead author M...

Jan 19th, 2021 - (Reuters) - The U.S. Supreme Court on Tuesday rejected Merck & Co Inc's bid to revive a $2.54 billion jury verdict it won against rival drugmaker Gilead Sciences Inc for infringing a patent in a dispute over a blockbuster hepatitis C treatment. Th...

Jan 14th, 2021 - HCC is relatively uncommon in the United States, although its incidence is rising, principally in relation to the spread of hepatitis C virus infection.[2] Worldwide, HCC is the sixth most prevalent cancer and the third leading cause of cancer-rel...